PHARMACY

CCPA advocates supporting pharmacists in their integral roles in health care

BY Jenna Duncan

ALEXANDRIA, Va. The Coalition for Community Pharmacy Action—comprised of the National Association of Chain Drug Stores and the National Community Pharmacists Association—has released survey results that show that 69 percent of probabalye voters view health care as a “top five” concern in considering presidential candidates this year. Also, those surveyed said that pharmacists play a key role in healthcare delivery system.

The survey pool was comprised of 800 likely voters polled by phone by the survey company WomanTrend. Results showed likely voters said pharmacists were “vital” to health care and most trusted for their accessibility and dependability—of those surveyed, 92 percent said pharmacists are easy to reach and helpful with providing facts about prescription medicines and general health care.

Seventy-nine percent of survey participants expressed an interest in speaking with a pharmacist to learn how to take their medications properly and also to prevent possible drug interactions.   

“Community pharmacy has long been committed to articulating the value of pharmacists,” said NACDS President and chief executive officer Steve Anderson and NCPA chief executive officer, executive vice president Bruce Roberts.  “Now with the current economic situation, that value is even greater as pharmacists can help patients manage their health, and take their prescription medications appropriately to avoid increased healthcare costs during these challenging financial times.” 

“Pharmacists are highly educated, convenient and accessible healthcare providers,” Anderson and Roberts said. 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?
PHARMACY

McKesson reports earnings increase for Q2 2008

BY Jenna Duncan

SAN FRANCISCO McKesson Co. reported Wednesday that its earnings for second quarter 2008 which ended Sept. 30 totaled $26.6 billion, up 9 percent from $24.5 billion at the same time last year.

“We had a solid quarter, with a particularly strong performance from Distribution Solutions despite industry concerns about lower prescription trends,” John H. Hammergren, chairman and chief executive officer said in a statement. “In Technology Solutions, our second quarter operating profit was up 8 percent year-over-year, although we did begin to see some customers delay their purchasing decisions.”

Second-quarter diluted earnings were $1.17 per share, up 41 percent from 83 cents per diluted share last year. That total included 27 cents per share from a $76 million tax reserve release and five cents per share after sale of the 42 percent holdings of Verispan, the company reported. McKesson benefited from the sale of its specialty pharmacy business Distribution Solutions, a business within McKesson Specialty Care Solutions.

McKesson also said that its second-quarter earnings totals included $25 million in pre-tax share-based compensation expense, versus its pre-tax expense of $28 million one year ago.

The company said that projections for 2009 earnings were reported at $4.00 to $4.15 per diluted share.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?
PHARMACY

CVS completes tender for Longs Drugs acquisition

BY Antoinette Alexander

WOONSOCKET, R.I. CVS Caremark has successfully completed the subsequent offering period of its tender offer for all of the outstanding common stock of Longs Drug Stores, and expects to effect the merger on or about Oct. 30.

The subsequent offering period for the tender offer expired at 6 p.m., New York City time, on Oct. 28. A total of approximately 28,317,338 shares of Longs were tendered in the initial and subsequent offering periods of the offer, representing approximately 78.07 percent of the outstanding shares.

CVS expects to effect, without a vote or meeting of Longs’ stockholders, a short-form merger on or about Oct. 30 to complete the Longs acquisition.

In the merger, each of the remaining outstanding shares (other than any shares owned by CVS or its subsidiaries) will be converted into the right to receive the same $71.50 in cash per share, without interest, that was paid in the tender offer.

Following the merger, Longs’ common stock will cease to be traded on the New York Stock Exchange.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?